Skip to main content
Inovio Pharmaceuticals, Inc. (LON:0A43)
London flag London · Delayed Price · Currency is GBP · Price in USD
1.739
0.00 (0.00%)
At close: Apr 17, 2025

Inovio Pharmaceuticals Revenue

In the year 2024, Inovio Pharmaceuticals had annual revenue of $217.76K USD, down -73.83%. Inovio Pharmaceuticals had revenue of $116.99K in the quarter ending December 31, 2024, with 13.97% growth.

Revenue
$217.76K
Revenue Growth
-73.83%
P/S Ratio
296.84
Revenue / Employee
$1.63K
Employees
134
Market Cap
51.63M GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024217.76K-614.25K-73.83%
Dec 31, 2023832.01K-9.43M-91.89%
Dec 31, 202210.26M8.49M478.23%
Dec 31, 20211.77M-5.64M-76.05%
Dec 31, 20207.41M3.30M80.24%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 43.19B
Shell 227.10B
HSBC Holdings 48.93B
Unilever 50.25B
Rio Tinto Group 42.86B
RELX PLC 9.43B
British American Tobacco p.l.c. 25.87B
London Stock Exchange Group 8.86B
Revenue Rankings

Inovio Pharmaceuticals News

More News